baber/WOPTO huggingface dataset:
Patent DE-69521999-T2 (DE)
Inventor: YOUNG HARTLEY FRANK
IPC: E01B9/30
Filed: 1995-10-23
Granted: 2001-11-15
Abstract: An elastic rail clamp 10, for fastening a rail to an underlying rail plate or rail tie 1, of the type comprising a pair of substantially parallel members 19 folded into a D configuration so as to have a front toe portion 16 adapted to seat on a flange of the rail, which toe portion 16 is formed by respective free ends 18 of the substantially parallel members 19, and a base portion 11 adapted to seat in a slot 4 in the rail plate or rail tie 1, is shaped such that the parts 14 of the substantially parallel members 19 between the base portion 11 and the toe portion 16 are tapered in external dimensions towards the toe portion 16 of the clamp 10, and the free ends 18 of the substantially parallel members 19 are turned back toward a rear portion 13 of the clamp 10 and project outwardly so as to abut a portion of the rail plate or rail tie 1 when the clamp 10 is in use, thereby to prevent the rail clamp 10 sliding off the rail flange. Alternatively or in addition, the pair of substantially parallel members 19 are joined together between the curved rear portion 13 of the members 19 adjacent the base portion 11. <IMAGE>
Patent DE-69522334-T2 (DE)
Inventor: DESHAYES MICHEL
IPC: A45B25/18
Filed: 1995-09-29
Granted: 2002-06-20
Abstract: A collapsible and portable device for protecting persons from the elements. The device includes a handle (3) for grasping the device, and a protective canopy joined to the handle (3) via a fastening ring (6) and a set of ribs (11). The ribs (11) are slidable along the handle (3) via a slide ring and the protective canopy is stretched over the ribs (11). The protective device is remarkable in that at least one additional secondary canopy (2) is provided beneath the above-mentioned protective canopy (1) and may be extended by means of a corresponding set of ribs (12).
Patent DE-69522704-T2 (DE)
Inventor: BARTHOLOMEY MARTIN
IPC: A61K8/31
Filed: 1995-06-01
Granted: 2002-07-11
Abstract: The present invention is for mascara compositions having improved application characteristics. Said improvement is attributed to incorporation of a setting rate agent which delays the setting of the composition long enough to provide sufficient time to distribute the mascara in semi-liquid form onto the lashes as well as contribute to lash-thickening properties while avoiding negative aesthetics.
Patent DE-69523581-T2 (DE)
Inventor: HEERES JAN
IPC: A61K31/4427
Filed: 1995-03-29
Granted: 2002-07-11
Abstract: PCT No. PCT/EP95/01184 Sec. 371 Date Sep. 20, 1996 Sec. 102(e) Date Sep. 20, 1996 PCT Filed Mar. 29, 1995 PCT Pub. No. WO95/27704 PCT Pub. Date Oct. 19, 1995The invention is concerned with the compounds having the formula    <IMAGE>  (I)    <IMAGE>   the pharmaceutically acceptable acid addition salts and the stereochemically isomeric form thereof, wherein X and Y are CH or N; R1, R2 and R3 are hydrogen or C1-4alkyl; R4 and R5 are hydrogen, halo, C1-4alkyl, C1-4alkyloxy, hydroxy, trifluoromethyl, trifluoromethyloxy or difluoromethyloxy; R6 is C1-6alkyl, hydroxyC1-6alkyl, C1-4alkyloxyC1-6alkyl, phenyl or phenylC1-4alkyl; Z is C=O or CHOH; and IMAGE>  (a-3)   <IMAGE>  (a-4)   <IMAGE>  (a-5)   <IMAGE>  (a-6)   <IMAGE>  (a-7)  compositions comprising said compounds, processes for preparing the same and the use of these compounds for treating Helicobacter related diseases.
Patent DE-69526932-T2 (DE)
Inventor: MILLGARD LARS
IPC: H05B47/23
Filed: 1995-03-10
Granted: 2002-12-19
Abstract: The present invention pertains to a method and a system for synchronization of time slots to a part of an a.c. net frequency half cycle as well as an apparatus for performing the synchronization. More particularly it relates to a transfer method and a system for communication of pulse signals over a series cable powered by a constant current regulator for control and monitoring of lightings, lamps, sensors, detectors and other loads. It specifically relates to the technical field of control and monitoring of airfield lighting systems (TWY1, TWY2, TWY3, SB1, LO1) including sensors for Surface Movement and Guidance Control Systems (SMGCS).
Patent DE-69618820-T2 (DE)
Inventor: BLACK CAMERON
IPC: C07D307/33
Filed: 1996-10-29
Granted: 2002-06-20
Abstract: The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
Patent DE-69628028-T2 (DE)
Inventor: CRONSHAW JAMES
IPC: G01N21/90
Filed: 1996-02-01
Granted: 2004-04-08
Abstract: This invention provides a method and apparatus (100) for detecting small glass particles (12) in bottles (1) filled with beer (10). The beer (10) is caused to rotate with respect to the bottle (1), and successive images are obtained from the bottle by means of a CCD-camera (40) which is arranged such that its optical axis (41) makes an angle alpha of about 135° with the axis (13) of the bottle (1), which is illuminated from below. The successive images are subtracted from each other to detect refracted light emanating from glass particles. These measurements are repeated a plurality of times. The invention thus offers an improvement in sensitivity and reliability of a detecting method. An apparatus (100) comprises a carousel (103) with a plurality of cameras dedicated to a single bottle. A system is described to reduce costs by having eight cameras share one image processing unit.
Patent DE-69713094-T2 (DE)
Inventor: BELLET DOMINIQUE
IPC: C12Q1/6886
Filed: 1997-02-28
Granted: 2003-01-16
Abstract: A process for detecting malignant transformation of cells involves detecting the overexpression of the products of the beta3, beta5, beta8 and beta9 genes, which encode the hCGbeta subunit, relative to their expression in nonmalignant cells. A kit for diagnosing an hCG- or an hCG fragment-secreting cancer includes an assembly of polypeptides covering at least a part of the primary sequence of hCG. The use of a polypeptide corresponding to at least one portion of the primary sequence of hCG for producing a composition useful in hCG- or hCG fragment-secreting cancer immunotherapy is also disclosed.
Patent DE-69723721-T2 (DE)
Inventor: BEAURLINE M
IPC: A61K47/04
Filed: 1997-12-01
Granted: 2004-04-15
Abstract: Pharmaceutical gel formulations for topical drug delivery include drug, colloidal silicon dioxide, triacetin and, preferably, propylene glycol. The gel formulations are well suited for topical delivery of the drug 4-amino-2-ethoxymethyl-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol, which when applied topically induces cytokines, such as interferon and tumor necrosis factor, locally in the skin or mucous membranes of a mammal. The gel formulations are also well-suited for topical delivery of drugs for treatment of diseases involving skin and/or mucosal lesions because the gel formulations do not need to include irritating components.
Patent DE-69728556-T2 (DE)
Inventor: TOMLINSON ROD
IPC: A61K47/32
Filed: 1997-11-24
Granted: 2005-02-24
Abstract: The invention relates to a substantially homogenous liquid composition capable of percutaneous delivery of one or more physiologically active agents, the composition including a rate modulating polymer, a volatile solvent and at least one physiologically active agent, said rate modulating polymer being selected to enable modulation of the rate of delivery of said physiologically active agent. Methods of percutaneous delivery of active agents and of prophylactic or therapeutic antimicrobial, antifungal or antiviral treatment using the compositions of the invention are also described.
Patent DE-69734237-T2 (DE)
Inventor: BURCHELL BRIAN
IPC: G16H10/60
Filed: 1997-03-03
Granted: 2006-07-06
Abstract: The invention provides a method for improving the efficacy of drug trials, the method comprising the step of screening samples from potential participants for the genetic basis of Gilbert's Syndrome and eliminating or including potential participants in a drug trial in the knowledge of them possessing or not possessing the genetic basis of Gilbert's Syndrome.
Patent DE-69736526-T2 (DE)
Inventor: ENIKOLOPOV GRIGORI
IPC: A61K31/216
Filed: 1997-11-13
Granted: 2007-04-26
Abstract: The present invention is based on the discovery that nitric oxide (NO) is an important growth regulator in an intact developing organism. In particular, the present invention relates to a method of increasing in a mammal a population of hematopoietic stem cells in bone marrow which are capable of undergoing normal hematopoiesis and differentiation, wherein the bone marrow is contacted with an inhibitor of NO, such as an inhibitor of nitric oxide synthase (NOS), thereby producing bone marrow having an increased population of hematopoietic stem cells which are capable of undergoing normal hematopoiesis and differentiation. The present invention also relates to a method of increasing a population of cells in S phase in a tissue of a mammal, comprising contacting the tissue with an inhibitor of NO, such as an inhibitor of NOS. The invention also pertains to a method of regenerating tissue in an adult mammal comprising contacting a selected tissue (e.g., blood, skin, bone and digestive epithelium), or precursor cells of the selected tissue, with an inhibitor of NO, thereby inhibiting differentiation and inducing proliferation of cells of the tissue.
Patent DE-69805774-T2 (DE)
Inventor: ZELLER MARTIN
IPC: C07C311/06
Filed: 1998-02-23
Granted: 2003-03-06
Abstract: alpha-Amino acid amides of formula (I) wherein the substituents are defined as follows: n is a number zero or one; R1 to R7 are as defined herein; R8 is C1-C6alkyl, C3-C6alkenyl or C3-C6alkynyl; R9 is C3-C8cycloalkyl; a C1-C6alkyl, C3-C6alkenyl or C3-C6alkynyl group substituted by one or more halogen atoms; or a group (a) wherein p and q are identical or different and are each independently of the other a number zero or one; and R13, R14, R15 and R16 are identical or different and are each independently of the others hydrogen or C1-C4alkyl; X is hydrogen, in which case p and q must have the value zero; phenyl, unsubstituted or mono- or poly-substituted by halogen, nitro, cyano, carboxy, C2-C6alkenyl, C2-C6alkenyl, C1-C6haloalkyl, C3-C6alkenyloxy, C3-C6alkynyloxy, C3-C7cycloalkyl, C1-C6haloalkoxy, C1-C6alkylthio, C1-C6alkoxycarbonyl, C3-C6alkenyloxycarbonyl, C3-C6alkynyloxycarbonyl, C1-C6or by C1-C6alkoxy, cyano, -COOR17; -COR18 or a group (b) wherein R17 and R21 are each independently of the other hydrogen, C1-C6alkyl, C3-C6alkenyl or C3-C6alkynyl, and R18 is hydrogen; C1-C6alkyl, C2-C6</P
Patent DE-69809645-T2 (DE)
Inventor: IWASAKI TAKASHI
IPC: G02F1/09
Filed: 1998-07-03
Granted: 2003-08-14
Abstract: The microcapsule magnetic display sheet is sequentially provided thereon with a transparent front sheet, a microcapsule layer coated on the transparent front sheet and then a ultraviolet ray curable resin layer. The ultraviolet ray curable resin layer is formed by painting liquid ultraviolet raycurable resin on the microcapsule layer first and then hardeningit by irradiating it with UV rays. As the liquid ultraviolet ray curable resin can fill fine gaps of the microcapsules, no hollows left between the microcapsules and the UV resin layer. As the UV resin filled in gaps shares wording pressure, the microcapsules are fully protected and hardly be destroyed. After painting the liquid UV ray curable resin on the microcapsule layer and before it IS hardened, a separable film is covered on it. While a film is covered on it, the sheet is hard and if the film is separated, the sheet is soft. So the stiffness of the magnetic display sheet can be regulated by covering or not covering a film. <IMAGE>
Patent DE-69820225-T2 (DE)
Inventor: ROZ THIERRY
IPC: H02H9/04
Filed: 1998-03-18
Granted: 2004-11-18
Abstract: The protection structure (20) is connected to an external terminal (A) of a transponder (16) to be protected, connected to a transmitting/receiving antenna. The structure is formed from three diffusion zones (34,35,36) which are of a P<+> conductivity type and which are formed in an encasing zone (32) of an N<-> conductivity type formed in a semiconductor substrate (30) having a P<-> type of conductivity. Two (34,36) of the three zones are connected to a reference electrical potential (Vss), and the other zone (35) is connected to the external terminal.
Patent DE-69822165-T2 (DE)
Inventor: VANDER MAREN CHRISTIAN
IPC: A61F2/30
Filed: 1998-11-13
Granted: 2005-01-05
Abstract: The prosthesis shank, designed to be anchored in the medullary canal of a femur (3) by means of a filling compound or cement, comprises fixing (6) and assembly (7) sections. The fixing section has the form of a ship's bow, bulging from its distal tip (15) to its upper edge (14) where it meets the assembly section, and also its its proximal zone (16) from its median edge (1) to its opposite edge (1b), creating posterior (4) and anterior (5) bulges.
Patent DE-69825305-T2 (DE)
Inventor: KATO TADASHI
IPC: C09D11/30
Filed: 1998-09-10
Granted: 2005-07-14
Abstract: Disclosed are a process for the production of a low-molecular-weight allylamine polymer having a weight average molecular weight of 250 to 4,000 or an addition salt thereof, which comprises distilling a low-molecular-weight allylamine polymer solution to distill off unreacted monoallylamine, then, subjecting a residue to electrodialysis, and optionally carrying out acid treatment, a low-molecular-weight allylamine polymer having an ignition residue content of 5 % by weight or less and a weight average molecular weight of 250 to 4,000, or an addition salt of a low-molecular-weight allylamine polymer having said properties, a water-resistance-imparting agent for use in an ink which comprises the above polymer or addition salt, and an ink composition comprising a colorant and the above water-resistance-imparting agent. According to the process of the present invention, a low-molecular-weight allylamine polymer improved in coloring and almost free of an inorganic salt or an addition salt thereof can be efficiently obtained. Further, the ink composition comprising the low-molecular-weight allylamine polymer or the salt thereof, provided by the present invention, not only has high water resistance but also is excellent in shelf life, and it is suitably used for inkjet recording.
Patent DE-69825400-T2 (DE)
Inventor: WELFONDER KONRAD
IPC: F16D57/02
Filed: 1998-12-07
Granted: 2005-08-11
Abstract: A winding mechanism for controlling the retraction and deployment of an architectural covering, such as a window blind or shade having a winding element 12, about which the covering, or its lift cord or tapes are wound and unwound with rotation of the winding element about a first axis of rotation, and a fluid brake 40 for retarding the rotation of the winding element in at least one direction about the first axis. The fluid brake comprises a fluid tight compartment 42 containing a liquid and an impeller 46. The compartment and the impeller are adapted for relative rotation about a second axis, which can be the same as or coaxial with the first axis. Either the compartment or the impeller is operatively connected to the winding element. In operation the liquid rotates with the rotation of the compartment or the impeller about the second axis. Rotation of the liquid relative to the impeller or to the compartment in at least a first direction about the second axis is effective to retard the rotation of the winding element in at least a second direction about the first axis. The impeller 46, or a peripheral wall surface 43 of the compartment 42 has a first surface 49B that extends generally radially and substantially parallel with respect to the second axis. <IMAGE>
Patent DE-69832050-T2 (DE)
Inventor: HEALY MICHAEL
IPC: A61L27/00
Filed: 1998-04-06
Granted: 2006-07-06
Abstract: A composition suitable for implantation in soft tissue (for example at or around a body orifice) in order to augment the volume of soft tissue is produced. The particles, which are desirably irregularly shaped, are formed from a biodegradable phosphate glass, and may have an average particle diameter of 50 mum to 2000 mum, preferably 50 mum to 300 mum. The particles are used with a carrier medium for injection into soft tissue such as the bladder submucosa. This procedure can be applied to treat conditions such as vesicoureteric reflux. Additionally the procedure could be used cosmetically.
Patent DE-69833744-T2 (DE)
Inventor: COSTANTINI FRANCESCO
IPC: E04F10/06
Filed: 1998-12-24
Granted: 2006-11-16
Abstract: An articulated arm (7) for the support and extension of awnings (1), comprising a first and a second half-arms (8, 9) which are connected at respective close ends (11,12) by means of an intermediate joint (13) and each having a respective articulated end (15,16) opposed to said close end (11,12), said first and second half-arm (8,9) being movable between a non-operative bent position and an extended, supporting position of the articulated arm (7); an elastic member (21) connected to said first and second half-arm (8, 9), which opposes to the bending of said articulated arm (7); and loosening means (27) of said elastic member (21), which are joined with one of said first or second half-arm (8,9) which can be operated while said articulated arm (7) is the bent position. <IMAGE>
Patent DE-69905049-T2 (DE)
Inventor: RUBIN A
IPC: G01N21/77
Filed: 1999-07-13
Granted: 2003-11-20
Abstract: The present invention provides systems, methods, and screens to measure receptor internalization in a single step with appropriate automation and throughput. This approach involves luminescent labeling of the receptor of interest and the automated measurement of receptor internalization to a perinuclear location.
Patent DE-69906070-T2 (DE)
Inventor: RUSSO ANTONELLO
IPC: A01N41/06
Filed: 1999-06-14
Granted: 2003-12-04
Abstract: Liquid germicidal formulation containing, as the active ingredients, a combination of an alcohol and an organic N-chloroamine, which combination shows a high bactericidal activity and an unexpected stability in time, while maintaining its effectiveness substantially unchanged even after a prolonged storage. The formulation comprises, in water, chloramine-T or chloramine-B and one or more, aliphatic alcohols having up to 12 carbon atoms, preferably isopropanol, said solution having a pH not lower than 8.5.
Patent DE-69925496-T2 (DE)
Inventor: FASANO ALESSIO
IPC: A61K39/00
Filed: 1999-09-09
Granted: 2006-02-02
Abstract: Methods for using Zot or zonulin as an antigen specific inhibitor of APC activity and lymphocyte proliferation, being primarily useful in the field of immunoregulation and immunotherapy are described. Specifically, Zot and zonulin inhibit antigen presenting cell-mediated antigen-specific lymphocyte proliferation in a dose dependent manner. This effect is associated with the presence of a macrophage surface receptor to which Zot binds in a specific and saturable way. This down-regulation of the immune response is, at least in part, associated with a decreased uptake of antigen.
Patent DE-69925561-T2 (DE)
Inventor: GAUSS ROBERT C
IPC: G01R33/36
Filed: 1999-11-10
Granted: 2006-04-27
Abstract: A magnetic imaging apparatus includes an RF coil in electrical communication with an RF signal generator and a receiver through an interface circuit (E). The signal generator transmits resonance excitation signals at one of at least two resonance frequencies, e.g. the resonance frequencies of hydrogen helium 3, fluorine, phosphorous, carbon, or xenon. During the transmit cycle, PIN diode (30) is forward biased forming a filter at a first resonance frequency, electrically isolating the receiver from first frequency excitation signals. Simultaneously during the transmit cycle, PIN diode (32) is forward biased forming a filter at a second resonance frequency electrically isolating the receiver from second frequency excitation signals. During a receive cycle, the diodes are reverse biased turning both filters into low impedance circuits around the first and second resonance frequencies allowing a received magnetic resonance signal to pass unimpeded from the RF coil to the receiver. <IMAGE>
Patent DE-69931515-T2 (DE)
Inventor: SUGITA NAOKI
IPC: C12M1/26
Filed: 1999-10-20
Granted: 2006-10-05
Abstract: After supporting a chalet S having a culture medium K contained therein with a given thickness on a chalet holder 17 of a housing 14, a nozzle holder 13 is clamped at a top of the housing 14. When a motor 19 is energized to rotate a high static pressure fan 18, an air is introduced through nozzle openings 12a, and flows through a space between the nozzle 15 and the culture medium K. By setting a distance between the nozzle and the culture medium to 0.5-1.5 mm, a high collection efficiency can be attained. <IMAGE>
Patent DE-69933686-T2 (DE)
Inventor: MASUDA KOICHI
IPC: A61K38/22
Filed: 1999-07-30
Granted: 2007-08-23
Abstract: Provided herein are methods and devices for inducing the formation of functional replacement nonarticular cartilage tissues and ligament tissues. These methods and devices involve the use of osteogenic proteins, and are useful in repairing defects in the larynx, trachea, interarticular menisci, intervertebral discs, ear, nose, ribs and other fibrocartilaginous tissues in a mammal
Patent TR-200000449-T2 (TR)
Inventor: BARONE DANIEL LOUIS
IPC: B32B7/04
Filed: 1998-07-31
Abstract: The present invention relates to elastic laminate structures comprising an open cell polymeric mesh integrally thermal bonded between two fabric carrier layers and methods for manufacturing such laminates.
Patent TR-200002863-T2 (TR)
Title: Sert poliüretan köpük hazırlamaya mahsus yöntem
Inventor: HAMILTON ALAN JAMES
IPC: C08G18/38
Filed: 1999-03-17
Abstract: Bu bulus açik hücreli sert poliüretanli veya üretani degistirilmis poliizosiyanüratli köpükleri hazirlamaya mahsus bir yönteme, bu yöntemle hazirlanan köpüklere, bu köpüklerin bosaltilmis yalitim panolarinda kullanimina ve yöntem dahilinde faydali bazi yeni poliizosiyanat bilesimlerine iliskindir.
Patent TR-200003861-T2 (TR)
Title: Bir ekdison reseptörünü içeren bir gen anahtarı.
Inventor: JEPSON IAN
IPC: C07K19/00
Filed: 1996-05-20
Abstract: Bulus, genin distan kontrolünü mümkün kilan bir kimyasal indüsere karsilik veren bir gen anahtari olarak etkiyebilecek bir böcek steroid reseptör proteinine iliskindir.
Patent TR-200101816-T2 (TR)
Inventor: BELLONI ANTONIO
IPC: B23K9/028
Filed: 1999-12-21
Abstract: Two pipes are arranged, when forming a deep sea pipeline, end to end thereby defining a circumferentially extending narrow angled (less than 10 degrees) groove. Two arc welding torches are arranged directly adjacent to each other on a single carriage that moves around the pipes, thereby forming a twin arc welding system. The position of the arc of each torch is independently oscillated between the walls of the groove to form a weld therein. The arcs are guided automatically by an electronic guidance system, wherein electrical characteristics (such as arc current voltage and/or impedance) of the welding of each torch with regard to one of the two pipes are compared with the corresponding electrical characteristics relating to the other of the pipes. The position of an arc of a torch may thus be aligned with the center line of the groove.
Patent TR-200102273-T2 (TR)
Title: GNRH-II ihtiva eden kontrollü salınış formülasyonu.
Inventor: QI STEVE
IPC: C07K14/59
Filed: 1999-12-02
Abstract: Bir terapötik  peptidin veya tuzunun kontrollü salinisi için bir farmasötik formülasyon; bu peptit asagidaki diziyi haizdir: pyroGlu-His-Trp-Ser-Xaa1-Gly-Xaa2-Xaa3-Pro-Gly-NH2; bu dizide: Xaa1 His veya Tyr'dir; Xaa2 Trp veya Leu'dur; ve Xaa3 Tyr veya Arg'dir. Burada sart Xaa1 Tyr ve Xaa2 Leu oldugunda Xaa3 Arg degildir. Bu formülasyon ayrica farmasötik olarak kabul edilebilir, biyolojik olarak parçalanabilir bir  polimer ihtiva eder.